NOTE: SPECIAL BULLETIN COVID-19 #19 has been replaced in its entirety by SPECIAL BULLETIN COVID-19 #34: Telehealth Clinical Policy Modifications - Definitions, Eligible Providers, Services and Codes.
Topics Related to COVID-19
This Bulletin provides information to local Departments of Social Services (DSS) and NEMT providers on NC Medicaid’s requirements for NEMT services, the recommended safety procedures and protocols to help reduce the spread of COVID-19 and guidance.
Effective March 27, 2020, North Carolina Medicaid is requiring prior approval for hydroxychloroquine and chloroquine containing products. Prior approval is required to ensure beneficiaries continue to have access to these medications for maintenance of their autoimmune conditions, for treatment of malaria, and for treatment of extraintestinal amebiasis.
To offset potential hardships due to COVID-19, for NC Medicaid and Health Choice providers who were due to re-verify their enrollment between the dates of March 1, 2020 and June 30, 2020, NCTracks has reset your re-verification due date to Sept. 13, 2020.
The Centers for Medicare & Medicaid Services (CMS) has granted NC Medicaid the authority to temporarily modify several Medicaid and NC Health Choice policies retroactive to March 1, 2020, and through the end of federal emergency declaration or when the flexibility is ended by the State or CMS, whichever is first.
In this Medicaid Bulletin are descriptions of the 1135 waiver policy flexibilities:
In this Medicaid Bulletin are descriptions of the 1135 waiver policy flexibilities:
In response to the anticipated spread of the novel coronavirus (COVID-19) in North Carolina, NC Medicaid is adding the following diagnosis code to the list of diagnoses exempt from the annual visit limit:
Z20.828 - Contact with and (suspected) exposure to other viral communicable diseases
For additional information regarding NC Medicaid’s annual visit limit, please visit this website.
GDIT 800-688-6696
Z20.828 - Contact with and (suspected) exposure to other viral communicable diseases
For additional information regarding NC Medicaid’s annual visit limit, please visit this website.
GDIT 800-688-6696
In response to the anticipated spread of the novel coronavirus (COVID-19) in North Carolina, EviCore, NC Medicaid’s contracted vendor for imaging services, will auto-approve the following chest CT codes effective immediately:
The Outpatient Pharmacy point of sale (POS) adult and pediatric clinical edits for behavioral health medications will temporarily suspend effective March 23, 2020. These point of sale edits target dosages exceeding the FDA approved maximum limit and in class therapeutic duplication.
Effective March 23, 2020, if medically necessary, outpatient Respiratory Therapy (RT) services provided through the Independent Practitioner Provider (IPP) program that typically require prior authorization (PA), may be provided to NC Medicaid and NC Health Choice beneficiaries without PA. All other aspects of Clinical Coverage Policy 10D, Respiratory Therapy Services by Independent Practitioner Provider will remain applicable.
Effective March 23, 2020, if medically necessary, the following additional respiratory equipment and supplies that typically require prior authorization (PA) may be provided to beneficiaries without first seeking PA: